A Single Agent Phase II Study of Depsipeptide (FK228)in

Project: Research project

Project Details

Description

A Single Agent Phase II Study of Depsipeptide (FK228)in the Treatment of Cutaneous T-cell Lymphoma
StatusFinished
Effective start/end date2/9/066/30/08

Funding

  • CHARLES RIVER LAB, INC